Company Performance - InfuSystems Holdings, Inc. reported quarterly earnings of $0.12 per share, exceeding the Zacks Consensus Estimate of $0.03 per share, and showing a significant increase from earnings of $0.03 per share a year ago, resulting in an earnings surprise of +300.00% [1] - The company posted revenues of $36 million for the quarter ended June 2025, which was a slight miss compared to the Zacks Consensus Estimate by 0.27%, but an increase from year-ago revenues of $33.7 million [2] - Over the last four quarters, InfuSystems has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Stock Performance - InfuSystems Holdings shares have declined approximately 30.8% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The current Zacks Rank for InfuSystems is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $38.25 million, and for the current fiscal year, it is $0.10 on revenues of $147.05 million [7] - The outlook for the Medical - Products industry, to which InfuSystems belongs, is currently in the bottom 38% of over 250 Zacks industries, suggesting potential challenges ahead [8]
InfuSystems Holdings, Inc. (INFU) Tops Q2 Earnings Estimates